
Tarsus Unveils Exciting $100 Million Public Offering: A Game-Changing Opportunity Awaits!
Tarsus Pharmaceuticals Announces $100.0 Million Public Offering of Common Stock IRVINE, Calif., March 12, 2025 – Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS), a biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of rare and complex diseases, made an exciting announcement today. The company revealed its intention to raise funds through an underwritten public…